Recurring concern
Inadequate informed-consent processes for medical treatment
First reported 1 Jul 2014•Latest report 28 Dec 2025
What this concern includes
Includes failures of medical-treatment consent processes, including initiation, information about material risks, time for consideration, consistency of procedure, assessment of consent and documentation, where the failure is directly tied to obtaining valid informed consent.
Not included
- Excludes legal-status or detention transfers that do not concern consent to medical treatment.
- Excludes general communication, training, documentation or staffing deficiencies unless they are directly tied to the medical-treatment consent process.
- Excludes clinical assessment or treatment-selection failures that do not concern obtaining or recording informed consent.
- Reports
- 31
- Individual concerns
- 37
- Date range
- 2014–2025
- Stated actions
- 56
Distinct published reports
A report can raise multiple concerns
First to latest report issue date
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
-
Concerns raised1
Insufficient time for trial information review and informed consent before procedures
This report raised 7 other concerns. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Data last updated 7 September 2026